Federal Register / Vol. 76, No. 19 / Friday, January 28, 2011 / Notices 5179 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–10112 and CMS– 

287–05] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension without change of a 

currently approved collection; Title of 

Information Collection: Phone Surveys 

of Products and Services for Medicare 

Payment Validation and Supporting 

Regulations in 42 CFR 405.502. Use: 

The phone surveys of products and 

services for Medicare payment 

validation and supporting regulations in 

42 CFR 405.502 will be used to identify 

specific products/services provided to 

Medicare beneficiaries and the costs 

associated with the provision of those 

products/services. The information 

collected will be used to validate the 

Medicare payment amounts for those 

products/services and institute revisions 

of payment amounts where necessary. 

The respondents will be the companies 

that have provided the product/service 

under review to Medicare beneficiaries. 

Form Number: CMS–10112 (OMB# 

0938–0939); Frequency: Occasionally; 

Affected Public: Private sector— 

business or other for-profit; Number of 

Respondents: 4,000; Total Annual 

Responses: 4,000; Total Annual Hours: 

16,000. (For policy questions regarding 

this collection contact Michael Rich at 

410–786–6856. For all other issues call 

410–786–1326.) 

2. Type of Information Collection 

Request: Extension without change of a 

currently approved collection; Title of 

Information Collection: Chain Home 

Office Cost Statement and supporting 

Regulations in 42 CFR 413.17 and 

413.20; Use: The Form CMS–287–05 is 

filed annually by Chain Home Offices to 

report the information necessary for the 

determination of Medicare 

reimbursement to components of chain 

organizations. However, where 

providers are components of chain 

organizations, information included in 

the chain home office cost statement is 

in addition to that included in the 

provider cost report and is needed to 

determine whether payments are 

appropriate. Form Number: CMS–287– 

05 (OMB# 0938–0202); Frequency: 

Yearly; Affected Public: Business or 

other for-profit and not-for-profit 

institutions; Number of Respondents: 

1,541; Total Annual Responses: 1,541; 

Total Annual Hours: 718,106. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web Site 

at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or 

E-mail your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

In commenting on the proposed 

information collections please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 

be submitted in one of the following 

ways by March 29, 2011: 

1. Electronically. You may submit 

your comments electronically to http:// 

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number, Room C4–26–05, 7500 

Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Martique Jones, 

Director, Regulations Development DivisionB, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2011–1865 Filed 1–27–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0464] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Testing 

Communications on Biological 

Products 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by February 

28, 2011. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or e-mailed to 

oira_submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910—New and 

title ‘‘Testing Communications on 

Biological Products.’’ Also include the 

FDA docket number found in brackets 

in the heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Johnny Vilela, Office of Information 

Management, Food and Drug 

Administration, 1350 Piccard Dr., PI50– 

400B, Rockville, MD 20850, 301–796– 

7651, Juanmanuel.vilela@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Testing Communications on Biological 

Products—(OMB Control Number 

0910—New) 

FDA is authorized by section 

1003(d)(2)(D) of the Federal Food Drug 

and Cosmetic Act (21 U.S.C. 

393(d)(2)(D)) (Attachment 2) to conduct 

educational and public information 

programs relating to the safety of 

regulated biological products. FDA must 

conduct needed research to ensure that 

such programs have the highest 

likelihood of being effective. FDA 

expects that improving communications 

about biological products including 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES